Why are drug prices so high? Investigating th...

Everything successful starts with heart — even the most pragmatic business plan, says Sharon Price John, CEO of Build-A-Bear. She shares how she led a purpose-centered approach to save the beloved teddy bear company from bankruptcy and get it back to global profitability, all by ...  Show more

What if kindness isn’t a soft skill — but a strategic one?In this special episode from Think Fast, Talk Smart, host Matt Abrahams talks with management professor Bonnie Hayden Cheng about the business case for kindness. Her research on the “return on kindness” suggests that organ ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

Between 2006 and 2016, the number of drug patents granted in the United States doubled -- but not because there was an explosion in invention or innovation. Drug companies have learned how to game the system, accumulating patents not for new medicines but for small changes to exi ...  Show more

For decades, drugmakers have argued that patents are critical to bringing new drugs to the market. But in 2004, when a promising H.I.V. treatment emerged, Gilead Sciences decided to slow-walk its release to maximize profit on the company’s existing patents.

Rebecca Robbi ...

Back in the 1990s, Dr. Raghunath Mashelkar was in his office in New Delhi when he came across a puzzling story in the newspaper. Some university scientists in the U.S. had apparently filed a patent for using turmeric to help heal wounds. Mashelkar was shocked, because he knew tha ...  Show more